Affiliate

Vet Portal

No products in the cart.

OncoGx16 uses state-of-the-art DNA energetic technology to detect early changes in DNA structure that are indicative of neoplastic cell transformation.  The test has a 98% sensitivity and a specificity reaching 99.5% based on a clinical study of validated cohorts comprising hundreds of dogs, with and without a diagnosis of cancer for the 16 types of targeted canine cancer.